This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Numis Securities | |
|---|---|
| Name | Numis Securities |
| Type | Private (formerly public) |
| Industry | Investment banking |
| Founded | 1989 |
| Headquarters | London, United Kingdom |
| Key people | See section on Corporate governance and leadership |
| Products | Equity research, sales and trading, corporate finance, ECM, advisory |
Numis Securities Numis Securities is a London-based independent investment bank and securities firm offering corporate finance, equity research, sales and trading, and advisory services to listed and unlisted companies. Founded in 1989, the firm has been active in initial public offerings, secondary placements, mergers and acquisitions mandates, and capital markets transactions across the London Stock Exchange, AIM, and international markets. Numis has served clients ranging from small-cap companies to multinational corporations and has engaged with institutional investors such as BlackRock, Vanguard, State Street Corporation, and Fidelity Investments.
Numis traces its origins to a succession of merchant banking and stockbroking activities in the City of London during the late 20th century, emerging as a distinct firm in 1989 amid the aftermath of the Big Bang reforms and a wave of consolidation that included houses like Barclays Capital, Morgan Stanley, and Goldman Sachs. Throughout the 1990s and 2000s Numis expanded its equity research roster, competing with firms including Nomura Holdings, Jefferies Financial Group, Canaccord Genuity, and Panmure Gordon. The firm participated in prominent transactions alongside corporate clients and advisors such as GlaxoSmithKline, AstraZeneca, Rolls-Royce Holdings, and British Telecom, and operated through periods of market stress including the 2008 financial crisis and the European sovereign debt crisis. In the 2010s Numis navigated regulatory changes following events like the Global Financial Crisis and reforms prompted by the Vickers Report and interacted with institutions such as the Financial Conduct Authority and the Bank of England. The firm underwent structural and ownership changes in the 2020s amid takeover approaches and consolidation in investment banking involving competitors such as Rothschild & Co, Lazard, and Evercore.
Numis operated as a partnership-style stockbroking and investment banking business before converting to a corporate structure and listing on the London Stock Exchange in a flotation that involved arrangements familiar to peers such as Berenberg Bank and Cenkos Securities. Its ownership history includes private equity and institutional shareholdings similar to stakes held by 3i Group, Permira, CVC Capital Partners, and investor coalitions comprising Pension Protection Fund-style entities and sovereign wealth-like investors such as Abu Dhabi Investment Authority-type funds. Corporate restructuring over time aligned Numis with governance expectations set by bodies like Companies House and influenced by directives from the European Securities and Markets Authority. Board-level share allocations and management incentives mirrored practices at firms including HSBC, Barclays, and Deutsche Bank.
Numis provides a suite of capital markets and advisory services comparable to those offered by UBS, Credit Suisse, Morgan Stanley, and Goldman Sachs Group. Core services include equity research covering sectors akin to pharmaceuticals innovators represented by names like GlaxoSmithKline and AstraZeneca; corporate finance and ECM for issuers similar to BP spin-offs; sales and trading with counterparties such as Citigroup, J.P. Morgan, and Merrill Lynch; and mergers and acquisitions advisory comparable to mandates undertaken by Lazard and Rothschild & Co. Numis’ client base has included household-name issuers on markets like NASDAQ, New York Stock Exchange, and the Toronto Stock Exchange, as well as growth companies listed on AIM and the London Stock Exchange Group.
Numis has maintained a niche as a specialist equity-focused boutique within a competitive landscape featuring Goldman Sachs, Morgan Stanley, Barclays, Citi, and boutique rivals such as Canaccord Genuity and Cenkos Securities. Its market share in UK equity issuance and secondary trading placed it among leading advisers for small- and mid-cap offerings, frequently appearing in league tables alongside Numis' peers. Revenue and profitability across recent financial years were influenced by equity market volatility tied to events like Brexit, the COVID-19 pandemic, and shifts in monetary policy from the European Central Bank and the Bank of England. Numis’ financial statements reflected fee income from ECM, advisory fees from M&A, and trading-related income similar to disclosures by Stifel Financial, Jefferies, and Rothschild. Capital adequacy and liquidity were managed to meet Basel III-inspired standards and expectations set by the Financial Conduct Authority.
Numis faced regulatory scrutiny and market controversies similar in nature to episodes involving other investment banks, intersecting with investigations by bodies including the Financial Conduct Authority and the Prudential Regulation Authority. Issues in the sector have historically included concerns about research independence, execution allocation, conflicts of interest highlighted in probes that also touched firms like Goldman Sachs and UBS, and compliance with transparency rules influenced by the Markets in Financial Instruments Directive reforms. Litigation and client disputes in the industry have involved counterparties and institutional investors such as Aberdeen Standard Investments, Aviva Investors, and sovereign-like institutions, with outcomes affecting reputations across the advisory community. Regulatory settlements and internal remediation programs paralleled those implemented by Deutsche Bank and Barclays in response to supervisory findings.
Leadership at Numis comprised executives and non-executive directors with backgrounds at institutions including Barclays, HSBC, Morgan Stanley, Credit Suisse, Rothschild & Co, and Lazard. Senior management teams typically featured heads of equity research, corporate finance, sales, and trading with previous roles at firms like Goldman Sachs Group, J.P. Morgan, UBS, and Jefferies Financial Group. Governance practices adhered to codes of conduct informed by the UK Corporate Governance Code and reporting obligations to regulators such as the Financial Conduct Authority. External auditors and advisers in governance matters have included names like PwC, KPMG, Deloitte, and Ernst & Young, while legal counsel for transactions often involved firms such as Clifford Chance, Freshfields Bruckhaus Deringer, and Linklaters.
Category:Financial services companies of the United Kingdom